iTeos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Core Viewpoint - iTeos Therapeutics, Inc. is set to present at the 43rd Annual J.P. Morgan Healthcare Conference, highlighting its focus on immuno-oncology therapeutics [1] Company Overview - iTeos Therapeutics is a clinical-stage biopharmaceutical company specializing in the discovery and development of immuno-oncology therapeutics [3] - The company utilizes its expertise in tumor immunology and immunosuppressive pathways to create novel product candidates aimed at enhancing the immune response against cancer [3] - iTeos has three clinical-stage programs targeting validated immunosuppressive pathways, designed for improved clinical outcomes [3] - The company is headquartered in Watertown, MA, with a research center located in Gosselies, Belgium [3] Presentation Details - Michel Detheux, Ph.D., President and CEO of iTeos, will present on January 15, 2025, at 7:30 AM PST (10:30 AM EST) [1] - A live webcast of the presentation will be available on the company's website, with an archived replay accessible for approximately 30 days post-presentation [2]